Barbital
| Barbital | |
|---|---|
| Salts [] | |
|---|---|
| Sodium barbital | |
| Barbital hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 184.19 g/mol [1] |
| Melting point | 190 °C [1] |
| Boiling point | 250 °C at 2.20E+01 mm Hg [1] |
| Solubility | 7460 mg/L (at 25 °C) [1] |
| Predicted LogP | 0.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C8H12N2O3 |
| IUPAC name | 5,5-diethyl-1,3-diazinane-2,4,6-trione |
| SMILES | CCC1(C(=O)NC(=O)NC1=O)CC |
| InChI | InChI=1S/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13) |
| InChIKey | FTOAOBMCPZCFFF-UHFFFAOYSA-N |
| CAS number | 57-44-3 |
| UNII | 5WZ53ENE2P |
| PubChem CID | 2294 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 30.3 (± 3.2) hours |
| Routes of administration | By mouth |
Barbital (also known as Barbitone, 5,5-Diethylbarbituric acid, Diethylmalonylurea, Ethylbarbital, Diemal, DEBA, 5,5-diethylpyrimidine-2,4,6(1H,3H,5H)-trione, 200-331-2, Veronal or Malonal) is a substance of the barbiturate class.
Chemistry
Salts []
Barbital is typically found in the form of its sodium and hydrochloride salts.
Stereochemistry []
Barbital is achiral.
Druglikeness
Lipinski's rule of five
Barbital matches Lipinski's rule of five.Reagents
There are currently 3 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change | |
| Mandelin | no color change |
Pharmacology
ATC Classification
- nervous system (N)
- psycholeptics (N05)
- hypnotics and sedatives (N05C)
- barbiturates, plain (N05CA)
- barbital (N05CA04)
MeSH Classification
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| GABRA1 | shared target | 32 |
|---|---|---|
| GABRA2 | shared target | 32 |
| GABRA3 | shared target | 32 |
| GABRA4 | shared target | 32 |
| GABRA5 | shared target | 32 |
| GABRA6 | shared target | 32 |
| GABRB1 | shared target | 32 |
| GABRB2 | shared target | 32 |
| GABRB3 | shared target | 32 |
| GABRD | shared target | 32 |
| GABRE | shared target | 32 |
| GABRG1 | shared target | 32 |
| GABRG2 | shared target | 32 |
| GABRG3 | shared target | 32 |
| GABRP | shared target | 32 |
| GABRQ | shared target | 32 |
Legal status []
- Brazil: Barbital is a B1.[3]
- Canada: Barbital is a Schedule IV.
- United States: Barbital is a Schedule IV under the "Controlled Substances Act".
- Germany: Barbital is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 2294, Barbital. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/2294
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Barbital. UNII: 5WZ53ENE2P. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/5WZ53ENE2P
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 18:01:32 |
| drugspro | ok | 2026-11-20 18:01:28 |
| erowid | ok | 2026-11-20 18:01:30 |
| gsrs | ok | 2026-11-20 18:01:29 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0248870) | 2026-11-20 18:01:28 |
| kegg | ok | 2026-11-20 18:01:30 |
| pubchem | ok | 2026-11-20 18:01:27 |
| missing (no r/tripreports posts mention it) | 2026-11-20 18:01:28 | |
| sider | missing (not in SIDER) | 2026-11-20 18:01:28 |
| structure | ok | 2026-11-20 18:01:28 |
| wikipedia | ok | 2026-11-20 18:01:28 |